Introduction
The clinical features of retroperitoneal fibrosis (Lepor and Walsh, 1979) and mediastinal fibrosis (Light, 1978) are protean. The aetiology of the majority of cases is unknown, but coexistence of these two rare conditions and their association with other fibrotic disorders suggest that they may be different manifestations of a single disease (Comings et al., 1967) . In some reported cases of combined retroperitoneal and mediastinal fibrosis, complications of mediastinal disease appeared many years after the diagnosis of retroperitoneal fibrosis, or Despite his poor condition, it was decided that chemotherapy might be beneficial and he was given adriamycin/vincristine followed by methotrexate/ cyclophosphamide. Over the next 3 weeks, he deteriorated rapidly and died.
At necropsy, no tumour was found in any intrathoracic structure. The aorta was surrounded by dense fibrous tissue up to 0 5 cm thick extending from the ascending portion to the arch. The origins of the pulmonary arteries were similarly encased but the pulmonary veins were spared. The pelvic and leftsided retroperitoneal tissues also showed dense fibrous thickening which surrounded the left ureter and iliac vessels. The left kidney was hydronephrotic and its ureter was dilated proximally. Histologically, the affected mediastinal and retroperitoneal tissues showed dense hyaline fibrosis. The left kidney also showed some interstitial fibrosis, and the right kidney had changes of chronic pyelonephritis.
Discussion
Mediastinal fibrosis was discovered at necropsy in this patient 13 years after the initial diagnosis of retroperitoneal fibrosis. Although oat cell carcinoma is notoriously difficult to diagnose on pleural biopsy, chemotherapy was administered because it is potentially beneficial. No tumour was found at postmortem examination, and the patient probably died of ischaemic heart disease and intractable cardiac failure.
Coexisting retroperitoneal and mediastinal fibrosis is rare. Since the initial report by Tubbs (1946) , probably fewer than 40 cases have been recorded in the medical literature, although the true incidence is probably higher (Morgan, Loughridge and Calne, 1966) . The fibrotic lesions are usually anatomically separate, but fibrosis extending continuously from the retroperitoneum to the mediastinum has been described in at least 2 cases (Cameron et al., 1961; Light, 1978) . Most patients had symptoms referrable either to the abdomen or the thorax only, but a substantial proportion had clinical features of disease in both sites. The commonest presenting feature of retroperitoneal fibrosis is pain associated with obstructive uropathy (Lepor and Walsh, 1979) ; while that of mediastinal fibrosis is superior vena caval obstruction (Light, 1978) . However, many other structures such as the inferior vena cava, iliac vessels, pulmonary vessels, tracheobronchial tree, oesophagus ar,d coronary artery may be directly involved, giving rise to protean manifestations.
In addition, association with auto-immune disorders and other inflammatory fibrotic lesions in anatomically remote sites have been described. Examples of the latter include Riedel's thyroiditis, pseudotumour of the orbit and sclerosing cholangitis (Comings et al., 1967) . The term 'multifocal fibrosclerosis' has been used to describe various combinations of these conditions.
There are many reported causes of retroperitoneal fibrosis (Manna et al., 1981) amongst which tuberculosis and histoplasmosis can also cause mediastinal fibrosis. Nevertheless, in most patients, the aetiology is unknown. In these idiopathic cases, treatment with steroids in the early stages has been reported to be effective, whereas in later stages, surgery to relieve obstruction may be the only alternative (Longmire, Goodwin and Buckberg, 1967) .
Several possible mechanisms may be responsible for dyspnoea in mediastinal fibrosis. These include tracheal or bronchial compression, fibrotic narrowing of coronary arteries leading to ischaemic heart disease and cardiac failure, obstruction of main pulmonary arteries, obstruction of main pulmonary veins, thromboembolic occlusion of small intrapulmonary arteries and pulmonary interstitial fibrosis (Arnett et al., 1977) . Although this patient's left coronary artery was narrowed, and his pulmonary arteries encased, the degree of obstruction attributable to mediastinal fibrosis was not sufficient to account for his dyspnoea and intractable heart failure. He probably died from unrelated ischaemic heart disease. Nevertheless, since some of the above mechanisms are potentially treatable, further investigation of such patients may be warranted. Finally, in any patient with either retroperitoneal or mediastinal fibrosis, one should be alert to complications arising from other sites which may also be affected by the fibrotic process.
